结肠直肠癌患者和健康个体的微生物群差异:对疫苗抗原发现的影响

Gordon C Ibeanu1, Adekunle B Rowaiye1,2, Joy C Okoli1

  • 1Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, 27707, USA.

ImmunoTargets and therapy
|December 19, 2024
PubMed
概括

来自肠道细菌和病毒的微生物抗原对结直肠癌 (CRC) 疫苗有希望. 识别这些抗原是开发针对CRC的有效免疫疗法的关键.